Metropolitan Life Insurance Company (MetLife)’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,139
| Closed | -$123K | – | 1763 |
|
|
2024
Q1 | $123K | Sell |
4,139
-213
| -5% | -$6.66K | 0.01% | 941 |
|
|
2023
Q4 | $139K | Buy |
4,352
+459
| +12% | +$13.3K | 0.01% | 916 |
|
|
2023
Q3 | $114K | Buy |
3,893
+204
| +6% | +$7.33K | 0.01% | 941 |
|
|
2023
Q2 | $166K | Buy |
3,689
+981
| +36% | +$37.4K | 0.01% | 759 |
|
|
2023
Q1 | $93.3K | Sell |
2,708
-317
| -10% | -$10.3K | ﹤0.01% | 1018 |
|
|
2022
Q4 | $84.3K | Buy |
3,025
+622
| +26% | +$16.5K | ﹤0.01% | 1151 |
|
|
2022
Q3 | $56.2K | Hold |
2,403
| – | – | ﹤0.01% | 1385 |
|
|
2022
Q2 | $69.5K | Buy |
2,403
+324
| +16% | +$14.2K | ﹤0.01% | 1296 |
|
|
2022
Q1 | $114K | Sell |
2,079
-6,374
| -75% | -$315K | ﹤0.01% | 1112 |
|
|
2021
Q4 | $451K | Hold |
8,453
| – | – | 0.01% | 1515 |
|
|
2021
Q3 | $358K | Hold |
8,453
| – | – | 0.01% | 1662 |
|
|
2021
Q2 | $563K | Buy |
8,453
+677
| +9% | +$36.8K | 0.01% | 1451 |
|
|
2021
Q1 | $344K | Hold |
7,776
| – | – | 0.01% | 1661 |
|
|
2020
Q4 | $226K | Hold |
7,776
| – | – | ﹤0.01% | 1854 |
|
|
2020
Q3 | $170K | Sell |
7,776
-544
| -7% | -$9.67K | ﹤0.01% | 1875 |
|
|
2020
Q2 | $96.3K | Buy |
8,320
+6,374
| +328% | +$69.9K | ﹤0.01% | 2272 |
|
|
2020
Q1 | $12.7K | Sell |
1,946
-6,440
| -77% | -$91.8K | ﹤0.01% | 2474 |
|
|
2019
Q4 | $131K | Buy |
+8,386
| New | +$95.1K | ﹤0.01% | 2172 |
|
|
2019
Q3 | – | Sell |
-6,766
| Closed | -$55.1K | – | 2618 |
|
|
2019
Q2 | $55.1K | Hold |
6,766
| – | – | ﹤0.01% | 2495 |
|
|
2019
Q1 | $76.3K | Hold |
6,766
| – | – | ﹤0.01% | 2459 |
|
|
2018
Q4 | $66.2K | Hold |
6,766
| – | – | ﹤0.01% | 2488 |
|
|
2018
Q3 | $112K | Hold |
6,766
| – | – | ﹤0.01% | 2386 |
|
|
2018
Q2 | $101K | Hold |
6,766
| – | – | ﹤0.01% | 2311 |
|
|
2018
Q1 | $116K | Buy |
+6,766
| New | +$105K | ﹤0.01% | 2220 |
|
|
2017
Q3 | – | Sell |
-12,152
| Closed | -$276K | – | 2517 |
|
|
2017
Q2 | $276K | Hold |
12,152
| – | – | ﹤0.01% | 2135 |
|
|
2017
Q1 | $237K | Sell |
12,152
-5,264
| -30% | -$102K | ﹤0.01% | 2160 |
|
|
2016
Q4 | $276K | Sell |
17,416
-592
| -3% | -$9.84K | ﹤0.01% | 2145 |
|
|
2016
Q3 | $364K | Hold |
18,008
| – | – | ﹤0.01% | 1918 |
|
|
2016
Q2 | $322K | Buy |
18,008
+153
| +0.9% | +$2.28K | ﹤0.01% | 1981 |
|
|
2016
Q1 | $237K | Sell |
17,855
-689
| -4% | -$10.7K | ﹤0.01% | 2073 |
|
|
2015
Q4 | $380K | Buy |
+18,544
| New | +$354K | ﹤0.01% | 1810 |
|
Other funds holding SGRY
BCI
DM
DCP
Metropolitan Life Insurance Company (MetLife)'s SGRY Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Surgery Partners (SGRY) in Q2 2024, closing a stake of 4,139 shares — an estimated $123K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in SGRY in Q4 2015 and held it in 31 quarters. The position peaked at $563K in Q2 2021. 180 funds tracked by Wall St. Rank hold SGRY as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Surgery Partners position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 4,139 Surgery Partners shares in Q2 2024, an estimated $123K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Surgery Partners in Q4 2015 and held it in 31 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Surgery Partners position peaked at $563K in Q2 2021.
- 180 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.